Hiroshi Shiku mainly focuses on Immunology, Antigen, Molecular biology, Cytotoxic T cell and Pathology. His study in Antibody, Immunotherapy, Immune system, T cell and Cancer vaccine are all subfields of Immunology. The various areas that Hiroshi Shiku examines in his Antigen study include Cell culture, Cell and Chronic myelogenous leukemia.
His study in Molecular biology is interdisciplinary in nature, drawing from both Genetics, Gene expression, Gene, Cytotoxicity and CTL*. Hiroshi Shiku interconnects Fibrosarcoma and Cell biology in the investigation of issues within Cytotoxic T cell. His Pathology study combines topics from a wide range of disciplines, such as Cancer, Colorectal cancer, Cancer research and Pancreas.
Hiroshi Shiku mainly investigates Immunology, Molecular biology, Cancer research, Antigen and Internal medicine. His Immunology study typically links adjacent topics like Cell biology. His Molecular biology study deals with Cytotoxic T cell intersecting with CD8 and T cell.
His research in Cancer research intersects with topics in Cell culture, Colorectal cancer and Tumor antigen. His studies deal with areas such as Cancer, Cancer vaccine and Antibody as well as Antigen. His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology, Oncology and Pathology.
His primary areas of investigation include Immunology, Antigen, Cancer research, T cell and Cytotoxic T cell. His Antigen research incorporates elements of Cancer, Chimeric antigen receptor and Monoclonal antibody. His biological study spans a wide range of topics, including Cell culture, CD28, Sarcoma, Cell therapy and Tumor antigen.
His work deals with themes such as Cell, Peripheral blood mononuclear cell and CD8, which intersect with T cell. His study in Cytotoxic T cell is interdisciplinary in nature, drawing from both Molecular biology and Cell biology. Hiroshi Shiku works mostly in the field of Immune system, limiting it down to concerns involving Antibody and, occasionally, Adverse effect.
His primary areas of study are Immunology, Antigen, Immune system, Cancer research and Cytotoxic T cell. His Antigen research is multidisciplinary, incorporating perspectives in Cell therapy, Chimeric antigen receptor, Monoclonal antibody and Cancer immunotherapy. His work carried out in the field of Immune system brings together such families of science as Cancer, Tumor progression, Colitis and Cell biology.
His research in Cancer research focuses on subjects like Cell culture, which are connected to Major histocompatibility complex and In vivo. His Cytotoxic T cell study integrates concerns from other disciplines, such as T cell, Stromal cell and Mesenchymal stem cell. His IL-2 receptor study combines topics in areas such as Molecular biology and Antigen-presenting cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system
K Takamiya;A Yamamoto;K Furukawa;S Yamashiro.
Proceedings of the National Academy of Sciences of the United States of America (1996)
Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy
Holly L Hanson;David L Donermeyer;Hiroaki Ikeda;J.Michael White.
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients
Motoko Yamaguchi;Masao Seto;Masataka Okamoto;Ryo Ichinohasama.
Classification of current anticancer immunotherapies
Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué.
Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.
H Shiku;T Takahashi;H F Oettgen.
Journal of Experimental Medicine (1976)
Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.
Albert B. DeLEO;Hiroshi Shiku;Toshitada Takahashi;Mary John.
Journal of Experimental Medicine (1977)
Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells.
H Shiku;P Kisielow;M A Bean;T Takahashi.
Journal of Experimental Medicine (1975)
Serological analysis of cell surface antigens of malignant human brain tumors.
Michael Pfreundschuh;Hiroshi Shiku;Toshitada Takahashi;Ryuzo Ueda.
Proceedings of the National Academy of Sciences of the United States of America (1978)
Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody
M Haraguchi;S Yamashiro;A Yamamoto;K Furukawa.
Proceedings of the National Academy of Sciences of the United States of America (1994)
Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera
Eiichi Nakayama;Hiroshi Shiku;Elisabeth Stockert;Herbert F. Oettgen.
Proceedings of the National Academy of Sciences of the United States of America (1979)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: